Thomas Videbaek

Dr. Thomas Videbaek is a Chairman at Protera SAS, an Independent Non-Executive Director at Camlin Fine Sciences Ltd. and a Chief Executive Officer at Novozymes BioloAg A/S. He is on the Board of Directors at Camlin Fine Sciences Ltd., Novozymes Biopharma DK A/S, Evolva SA and Albumedix A/S. Dr. Videbaek was previously employed as a Non-Executive Director by Evolva Holding SA, an Executive VP-People, Sustainability & Brand by Novozymes A/S, a Vice President-Cereal Food & Beverage Marketing by Novozymes Switzerland AG, and a Director-Strategic Marketing by Novo Nordisk A/S. He also served on the board at Novozymes BioAg Group and Beta Renewables SpA. He received his undergraduate degree from Copenhagen Business School, a graduate degree from Technical University of Denmark and a doctorate degree from Technical University of Denmark.